| |
| |
|
| Insider
Information: |
Lange Louis G |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
582,756 |
|
|
Indirect Shares
|
228,940 |
|
|
| Direct
Value |
$89,007 |
|
|
|
Indirect Value
|
$466,579 |
|
|
| Total
Shares |
811,696 |
|
|
| Total
Value |
$555,586 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CV Therapeutics Inc |
CVTX |
Chairman & CEO, Director |
2009-04-09 |
483,618 |
2009-04-09 |
6,359 |
Premium* |
|
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
60,000 |
2009-09-22 |
0 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2013-07-01 |
17,814 |
2013-07-01 |
197,703 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
Director |
2013-10-11 |
1,446 |
|
0 |
Premium* |
|
|
Newamsterdam Pharma Ord Shs |
NAMS |
|
2023-12-29 |
19,878 |
2024-02-13 |
24,878 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-02-25 |
4 |
D |
$15.58 |
$346,967 |
D/D |
(22,270) |
335,668 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-02-25 |
4 |
OE |
$15.58 |
$779,000 |
D/D |
50,000 |
355,630 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-03-25 |
4 |
D |
$19.88 |
$99,897 |
D/D |
(5,025) |
341,988 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-03-25 |
4 |
OE |
$19.88 |
$225,539 |
D/D |
11,345 |
342,560 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-04-02 |
4 |
S |
$19.90 |
$9,535,583 |
D/D |
(479,175) |
503,896 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-04-02 |
4 |
OE |
$10.45 |
$7,693,930 |
D/D |
641,083 |
782,373 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-04-09 |
4 |
D |
$19.94 |
$404,343 |
D/D |
(20,278) |
483,618 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,314 |
14,314 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
186,989 |
186,989 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2013-07-01 |
4 |
B |
$14.00 |
$149,996 |
I/I |
10,714 |
197,703 |
2.1 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Director |
– • – |
2013-07-01 |
4 |
B |
$14.00 |
$49,000 |
D/D |
3,500 |
17,814 |
2.39 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2009-09-22 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
10,000 |
0 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2010-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
40,000 |
0 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2011-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
50,000 |
0 |
- |
|
| MAXY |
Maxygen Inc |
Director |
– • – |
2012-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
60,000 |
0 |
- |
|
| NAMS |
Newamsterdam Pharma Ord S... |
|
– • – |
2023-12-29 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
19,878 |
|
- |
|
| NAMS |
Newamsterdam Pharma Ord S... |
|
– • – |
2023-12-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,878 |
|
- |
|
| NAMS |
Newamsterdam Pharma Ord S... |
|
– • – |
2024-02-13 |
4 |
B |
$19.00 |
$95,000 |
I/I |
5,000 |
24,878 |
0.01 |
- |
|
68 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
